# Tyvaso DPI

NDC: 66302-780
Generic name: treprostinil
Labeler / Manufacturer: United Therapeutics Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INHALANT
Routes: ORAL
Marketing started: 20241024

FDA application: NDA214324

## Active ingredients

- TREPROSTINIL: 80 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66302-780"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66302-780
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddc3d400-bcb3-4b09-aae2-0768b10a5b0f